Immunosuppression dose reduction to prevent development of aggressive skin cancer after kidney transplantatio

Not Applicable

• Conditions: skin cancer; kidney transplantation; Cancer - Non melanoma skin cancer; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12614000864628
• Lead Sponsor: Robert Peter Carroll

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-08-12
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 98

Inclusion Criteria

Kidney transplant recipients with a previous squamous cell carcinoma of the skin
High levels of Regulatory T cells in peripheral blood
Low levels of allo reactive T cells measured by ELISPOT
Absence of donor specific allo antibodies

Exclusion Criteria

Presence of a donor specific antibody
High levels of allo reactive T cells in peripheral circulation
Low levels of Regulatory T cells in blood

Study & Design

• Study Type: Interventional
• Study Design: Not specified